Download PDF
Thromb Haemost 1968; 19(01/02): 236-241
DOI: 10.1055/s-0038-1651201
Originalarbeiten – Original Articles – Travaux Originaux
Schattauer GmbH

The Hypercoagulability in Mercury Chloride Intoxicated Dogs

K Worowski
1   Department of Physiological Chemistry (Head: Doc. Stefan Niewiarowski, M. D.), Medical School, Bialystok, Poland
› Author Affiliations
Further Information

Publication History

Publication Date:
27 June 2018 (online)

    Permissions and Reprints

Summary

Experimental acute mercury chloride intoxication has been produced in the dog by subcutaneous injection of HgCl2 in a daily dose of 3 mg/kg of weight for 3 days. The following features of hypercoagulability of dog blood have been found: increase of fibrinogen level, increase of factors II and VII, shortening of the thrombin and prothrombin times, shortening of the thromboelastographic “r” and “k” values, increase of “ma” and “me” values, increase of platelet adhesiveness. On the other hand plastic clotting time was slightly prolonged.

It has been postulated that hypercoagulability in the dog during mercury chloride intoxication is caused by the increase of inactive clotting factors. This may be connected with disturbances in the plasma protein balance in nephrosis.

 

  • References

  • 1 Astrup T, Müllertz S. The fibrin plate method for estimation fibrinolytic activity. Arch. Biochem. 1952; 40: 346
    CrossrefPubMedGoogle Scholar
  • 2 Barkhan P, Lai M, Stevenson M. Antihaemophilic factor (factor VIII) and alpha2-globulin. Brit. J. Haemat. 1963; 9: 499
    CrossrefPubMedGoogle Scholar
  • 3 Botti R.E, Ratnoff O.D. Studies on the pathogenesis of thrombosis: an experimental “hypercoagulable” state induced by the intravenous injection of ellagic acid. J. Lab. clin. Med. 1964; 64: 385
    PubMedGoogle Scholar
  • 4 Burstein M, Samaille J. Nouvelle methode de separation et de dosage des lipoproteines de faible densite. Ann. Biol. Clin. 1959; 17: 23
    PubMedGoogle Scholar
  • 5 Caen J. Is fibrinogen the plasma co-factor in ADP induced human platelet aggregation?. Nature (Paris) 1965; 205: 1120
    CrossrefPubMedGoogle Scholar
  • 6 Cross M.J. Effect of fibrinogen on the aggregation of platelets by adenosine diphosphate. Thrombos. Diathes. haemorrh. (Stuttg.) 1964; 12: 524
    PubMedGoogle Scholar
  • 7 Egeberg O. Blood coagulation in renal failure. Scand. J. clin. Lab. Invest. 1962; 14: 163
    CrossrefPubMedGoogle Scholar
  • 8 Galasiński W, Worowski K, Niewiarowski S, Franecki G. Turnover of 131I-fibrinogen in mercury chloride intoxicated dogs Thrombos. Diathes. haemorrh. 1967; 18: 268
    PubMedGoogle Scholar
  • 9 Girolami A, Clifton E.E. Hypercoagulable state induced in humans by the intravenous administration of purified ellagic acid Thrombos. Diathes. haemorrh. (Stuttg.) 1967; 17: 165
    PubMedGoogle Scholar
  • 10 Gross R, Nieth H, Mammen E. Blutungsbereitschaft und Gerinnungsstörungen bei Urämie. Klin. Wschr. 1958; 36: 107
    CrossrefPubMedGoogle Scholar
  • 11 Gurewich V, Thomas D.P. Pathogenesis of venous thrombosis in relation to its prevention by dextran and heparin. J. Lab. clin. Med. 1965; 66: 604
    PubMedGoogle Scholar
  • 12 Heinrich R.A, von der Heide E.C, Climie A.R. Cryofibrinogen formation and inhibition in heparinized plasma. Amer. J. Physiol. 1963; 204: 419
    PubMedGoogle Scholar
  • 13 Hellem A.J. The adhesiveness of human blood platelets in vitro. Scand. J. clin. Lab. Invest. Suppl. 1960; 22: 57
    PubMedGoogle Scholar
  • 14 Jeljaszewicz J, Niewiarowski S, Poplawski A, Prokopowicz J, Worowski K. Intravascular coagulation and fibrinolysis by staphylocoagulase Comparison with thrombin. Thrombos. Diathes. haemorrh. (Stuttg.) 1965; 13: 457
    PubMedGoogle Scholar
  • 15 Kendall A.G, Lowenstein L, Morgen R.O. The haemorrhagic diathesis in renal disease. Canad. med. Ass. J. 1961; 85: 405
    PubMedGoogle Scholar
  • 16 Lee L. Reticuloendothelial clearance of circulating fibrin in the pathogenesis of the generalized Shwartzman reaction. J. exp. Med. 1962; 115: 1065
    CrossrefPubMedGoogle Scholar
  • 17 Lesley Bidstrup P. Toxicity of mercury and its compounds. Elsevier; Amsterdam: 1964
    Google Scholar
  • 18 Lewis J.H, Zucker M.B, Ferguson J.H. Bleeding tendency in uremia. Blood 1965; 11: 1073
    PubMedGoogle Scholar
  • 19 Lorand L, Dickenman R.C. Assay method for the “fibrin-stabilizing factor”. Soc. exp. Biol. (N.Y.) 1955; 89: 45
    PubMedGoogle Scholar
  • 20 McLean J.R, Maxwell R.E, Hertler D. Fibrinogen and adenosine diphosphate induced aggregation of platelets. Nature (Lond.) 1964; 202: 605
    CrossrefPubMedGoogle Scholar
  • 21 Niewiarowski S, Prokopowicz J, Poplawski A, Worowski K. Inhibition of dog fibrinolytic system in experimental tubular necrosis of kidney. Experientia (Basel). 1964; 2: 99
    PubMedGoogle Scholar
  • 22 Niewiarowski S, Stuart R.K, Thomas D.P. Activation of intravascular coagulation by collagen. Proc. Soc. exp. Biol. (N. Y.) 1966; 123: 196
    CrossrefPubMedGoogle Scholar
  • 23 Niewiarowski S, Zywicka H, Latatto Z. Coagulation disorders in thrombocythemia. A study of seven cases Thrombos. Diathes. haemorrh. (Stuttg.) 1962; 7: 114
    PubMedGoogle Scholar
  • 24 Penick G.D, Dejanov I.I, Reddick R.L, Roberts H.R. Predisposition to intravascular coagulation. Thrombos. Diathes. haemorrh. (Stuttg.) 1966; 21: 543
    PubMedGoogle Scholar
  • 25 Quick A.J. The physiology and pathology of haemostasis, Kimpton. London: 1951
    Google Scholar
  • 26 Schultz F.H. Das Fibrinogen. VEB Georg Thieme; Leipzig: 1953
    Google Scholar
  • 27 Todd M.E. Coagulation studies in patients with the nephrotic syndrome and the uremic state. XIth Congress of the International Society of Haematology. Abstracts of papers; Sydney: 1966: 239 August
    Google Scholar
  • 28 Wall R.L. The use of serum protein electrophoresis in clinical medicine. A. M. A. Archives of Internal Medicine 1958; 102: 618
    CrossrefPubMedGoogle Scholar
  • 29 Wolfson M, Cohns C, Colvary E, Ichiba F. Studies in serum proteins. Amer. J. clin. Path. 1948; 18: 723
    PubMedGoogle Scholar
  • 30 Worowski K, Niewiarowski S, Prokopowicz J. Fibrinolysis and fibrinogen breakdown products (antithrombin VI) in renal venous blood (RVB) in dog. Thrombos. Diathes. heamorrh. (Stuttg.) 1964; 12: 87
    PubMedGoogle Scholar